Prevalence of gastrointestinal disorders in adult clients with pervasive developmental disorders

Journal of Intellectual Disability Research

Volumn 50, Issue 10, 2006, Pages 711-718

  Galli Carminati, Giuliana ^a   Chauvet, I ^a   Deriaz, N ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Behavioural disorders; Gastro intestinal disorders; Intellectual disability; Neuro organic comorbidity; Pervasive developmental disorders (PDD)

Indexed keywords

ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIULCER AGENT; ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; AUTISM; BEHAVIOR DISORDER; CLINICAL FEATURE; CLINICAL OBSERVATION; COMORBIDITY; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DUODENITIS; DUODENUM ULCER; DYSPEPSIA; ESOPHAGITIS; ESOPHAGUS ACHALASIA; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HEARTBURN; HIATUS HERNIA; HUMAN; MALABSORPTION; MALE; MEDICAL RECORD REVIEW; PREVALENCE;

ADULT; AGED; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 33748342980     PISSN: 09642633     EISSN: 13652788     Source Type: Journal    
DOI: 10.1111/j.1365-2788.2006.00833.x     Document Type: Article

References (36)

1. Accardo P. & Bostwick H. (1999) Zebras in the living room: The changing faces of autism. Journal of Pediatrics 135, 533-5.
2. Amiel J., Espinosa-Parrilla Y., Steffann J., Gosset P., Pelet A., Prieur M., Boute O., Choiset A., Lacombe D., Philip N., Le Merrer M., Tanaka H., Till M., Touraine R., Toutain A., Vekemans M., Munnich A. & Lyonnet S. (2001) Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. American Journal of Human Genetics 69, 1370-7.
3. Black C., Kaye J. A. & Jick H. (2002) Relation of childhood gastrointestinal disorders to autism: Nested case-control study using data from the UK General Practice Research Database. British Medical Journal 325, 419-21.
4. Bohmer C. J., Klinkenberg-Knol E. C., Niezen-de Boer R. C. & Meuwissen S. G. (1997a) The prevalence of gastro-oesophageal reflux disease based on non-specific symptoms in institutionalized, intellectually disabled individuals. European Journal of Gastroenterology and Hepatology 9, 187-90.
5. Bohmer C. J., Niezen-de Boer M. C., Klinkenberg-Knol E. C., Nadorp J. H. & Meuwissen S. G. (1997b) Gastro-oesophageal reflux disease in institutionalised intellectually disabled individuals. Netherlands Journal of Medicine 51, 134-9.
6. Bohmer C. J., Klinkenberg-Knol E. C., Niezen-de Boer M. C. & Meuwissen S. G. (2000a) Gastroesophageal reflux disease in mentally retarded persons: Prevalence, diagnosis and treatment. Nederlands Tijdschrift Voor Geneeskunde 144, 1156-61.
7. Bohmer C. J., Klinkenberg-Knol E. C., Niezen-de Boer M. C. & Meuwissen S. G. (2000b) Gastroesophageal reflux disease in intellectually disabled individuals: How often, how serious, how manageable? American Journal of Gastroenterology 95, 1868-72.
8. Bohmer C. J., Taminiau J. A., Klinkenberg-Knol E. C. & Meuwissen S. G. (2001) The prevalence of constipation in institutionalized people with intellectual disability. Journal of Intellectual Disability Research 45, 212-18.
9. Courchesne E. (1997) Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Current Opinion in Neurobiology 7, 269-78.
10. D'Eufemia P., Celli M., Finocchiaro R., Pacifico L., Viozzi L., Zaccagnini M., Cardi E. & Giardini O. (1996) Abnormal intestinal permeability in children with autism. Acta Paediatrica 85, 1076-9.
11. Galli-Carminati G. (1998) Le groupe sans mots (ou presque). Psychothérapies 18, 159-69.
12. Horvath K., Papadimitriou J. C., Rabsztyn A., Drachenberg C. & Tildon J. T. (1999) Gastrointestinal abnormalities in children with autistic disorder. Journal of Pediatrics 135, 559-63.
13. Hulland S. & Sigal M. J. (2000) Hospital-based dental care for persons with disabilities: A study of patient selection criteria. Special Care in Dentistry 20, 131-8.
14. Melmed R., Schneider C. K., Fabes R. A., Phillips J. & Reichelt K. (2000) Metabolic markers and gastrointestinal symptoms in children with autism and related disorders. Journal of Pediatric Gastroenterology and Nutrition 31, A 116 (Abstract).
15. Michaelis R. C., Skinner S. A., Deason R., Skinner C., Moore C. L. & Phelan M. C. (1997) Intersitial deletion of 20p: New candidate region for Hirschsprung disease and autism. American Journal of Medical Genetics 71, 298-304.
16. Reichelt K. L., Ekrem J. & Scott H. (1990) Gluten, milk proteins and autism: Dietary intervention effects on behavior and peptide secretion. Journal of Applied Nutrition 42, 1-11.
17. Reichelt K. L., Knivsberg A. M., Nödland M. & Lind G. (1994) Nature and consequences of hyperpeptiduria and bovine casomorphins found in autistic syndromes. Developmental Brain Dysfunction 7, 71-85.
18. Schopler E., Reichler R. J., DeVellis R. F. & Daly K. (1980) Toward objective classification of childhood autism: Childhood autism rating scale (CARS). Journal of Journal of Autism and Developmental Disorders 10, 91-103.
19. Schopler E., Mesibov G. B. & Hearsey K. (1995) Structured teaching in the TEACCH system. In: Learning and Cognition in Autism (eds E. Schopler & G. B. Mesibov), pp. 243-68. Plenum Press, New York.
20. Schultz S. T., Shenkin J. D. & Horowitz A. M. (2001) Parental perceptions of unmet dental need and cost barriers to care for developmentally disabled children. Pediatric Dentistry 23, 321-5.
21. Shattock P., Kennedy A., Rowell F. & Berney T. (1990) Role of neuropeptides in autism and their relationships with classical neurotransmitters. Brain Dysfunction 3, 328-45.
22. Solaas K. M., Skjeldal O., Gardner M. L. G., Kase B. F. & Reichelt K. L. (2002) Urinary peptides in Rett syndrome. Autism 6, 315-29.
23. Tanguay P. E., Edwards R. M., Buchwald J., Schwafel J. & Allen V. (1982) Auditory brainstem evoked responses in autistic children. Archives of General Psychiatry 39, 174-80.
24. Torrente F., Ashwood P., Day R., Machado N., Furlano R. I., Anthony A., Davies S. E., Wakefield A. J., Thomson M. A., Walker-Smith J. A. & Murch S. H. (2002) Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Molecular Psychiatry 7, 375-82, 334.
25. Van de Putte T., Maruhashi M., Francis A., Nelles L., Kondoh H., Huylebroeck D. & Higashi Y. (2003) Mice lacking zfhx1b, the gene that codes for smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome. American Journal of Human Genetics 72, 465-70.
26. Viander M., Heinaro I. & Happonon R.-P. (1989) Circulating antibodies and immune complexes in oral mucosal diseases. Proceedings of the Finnish Dental Society 85, 69-80.
27. Wakefield A. J. (1998) Autism, inflammatory bowel disease, and MMR vaccine. Lancet 351, 1356.
28. Wakefield A. J. & Montgomery S. M. (1999) Autism, viral infection and measles-mumps-rubella vaccination. Israel Medical Association Journal 1, 183-7.
29. Wakefield A. J., Murch S. H., Anthony A., Linnell J., Casson D. M., Malik M., Berelowitz M., Dhillon A. P., Thomson M., Harvey P., Valentine A., Davies S. E. & Walker-Smith J. A. (1998) Ileal-lymphoid-nodular Hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351, 637-41.
30. Wakefield A. J., Anthony A., Murch S. H., Thomson M., Montgomery S. M., Davies S., O'Leary J. J., Berelowitz M. & Walker-Smith J. A. (2000) Enterocolitis in children with developmental disorders. American Journal of Gastroenterology 95, 2285-95.
31. Wakefield A. J., Puleston J. M., Montgomery S. M., Anthony A., O'Leary J. J. & Murch S. H. (2002) Review article: The concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Alimentary Pharmacology and Therapeutics 16, 663-74.
32. Wakefield A. J., Harvey P. & Linnel J. (2004) MMR -responding to retraction. Lancet 363, 1327-8.
33. Wallace R. A., Webb P. M. & Schluter P. J. (2002) Environmental, medical, behavioural and disability factors associated with Helicobacter pylori infection in adults with intellectual disability. Journal of Intellectual Disability Research 46, 51-60.
34. Wallace R. A., Schluter P. J., Forgan-Smith R., Wood R. & Webb P. M. (2003) Diagnosis of Helicobacter pylori infection in adults with intellectual disability. Journal of Clinical Microbiology 41, 4700-4.
35. Wallace R. A., Schluter P. J. & Webb P. M. (2004a) Recurrence of Helicobacter pylori infection in adults with intellectual disability. International Medicine Journal 34, 132-3.
36. Wallace R. A., Schluter P. J. & Webb P. M. (2004b) Effects of Helicobacter pylori eradication among adults with intellectual disability. Journal of Intellectual Disability Research 48, 646-54.